Navigation program for young cancer survivors
Official title: Adaptation and Implementation of an Evidence-Based Patient Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Run by Kaiser Permanente · NCT07406087 · Data updated 2026-11-12
This project tests an adapted navigation program to help adolescent and young adult cancer survivors get timely care within Kaiser Permanente Southern California.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 45 Years |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Kaiser Permanente Academic / other |
| Locations | 1 site (Pasadena, California) |
| Status | Recruiting |
| Started | March 15, 2026 |
| Main results expected | June 2027 |
| Study ends | August 2027 |
| Registry record updated | July 6, 2026 |
| Trial ID | NCT07406087 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are ages 21-45 with a local or regional breast, ovarian, cervical, testicular, colorectal cancer (or similar listed) diagnosed between ages 15-39 and treated within KP Southern California, with Kaiser Permanente insurance.
✕Probably not a fit
Patients with leukemia, lymphoma, metastatic disease at diagnosis, or those not insured by Kaiser Permanente may have limited benefit from this navigation program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study will adapt an evidence-based patient navigation program for AYA cancer survivors and conduct a single-site pilot in the UG3 phase, training navigators and enrolling eligible patients. In the UH3 phase, it plans a pragmatic stepped-wedge trial to assess both clinical outcomes and implementation results across multiple data sources. The focus is on survivorship care coordination, surveillance, and access within the Kaiser Permanente Southern California system. The trial operates within its two-phase design, with progression to the UH3 phase contingent on milestone completion. The study excludes patients with leukemia, lymphoma, or metastatic disease at diagnosis and requires existing KP insurance coverage.
Why it matters
Potential benefit: If successful, patients could experience improved access to survivorship care and better coordination of follow-up within a familiar health system.
How similar studies have gone: Past navigation programs have shown benefits in survivorship care and care coordination, but adaptation for the AYA survivor population within a large integrated system is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Received diagnosis of local or regional breast, ovarian, cervical, testicular, colon/rectal, melanoma, endometrial, sarcoma, or thyroid cancer between the ages of 15-39 years ("index cancer")
* Current age 21-45 years
* Diagnosed and treated for index cancer within Kaiser Permanente Southern California adult medical oncology and/or surgery
* Current Kaiser Permanente insurance coverage
Exclusion Criteria:
* Patients with a history of or current diagnosis of leukemia or lymphoma
* Patients with metastatic disease at diagnosis
Where it's running
-
KP Southern California - Department of Research & Evaluation
Pasadena, California, United States Recruiting
Study contacts
- Principal investigator: Erin E Hahn, PhD — Kaiser Permanente Southern California, Department of Research & Evaluation
- Study coordinator: Erin E Hahn, PhD
- Email: Erin.E.Hahn@kp.org
- Phone: 626-564-3505
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Testing trastuzumab deruxtecan (T‑DxD) for HER2‑positive advanced solid tumors
This will test whether trastuzumab deruxtecan (T‑DxD) helps adults in the US with HER2‑positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have had prior systemic treatment and have no satisfactory alternative options.
-
Validation of a blood test for early cancer detection and monitoring
This study is testing a blood test to see if it can help find different types of cancer early and monitor patients after treatment.
-
A resource for collecting cancer data and biospecimens
This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.
-
Virtual exercise program to preserve function and prevent disability during chemotherapy
This trial tests whether supervised resistance sessions by video plus short home aerobic workouts help adults 18–64 maintain strength and stay active while receiving curative-intent chemotherapy.
-
Testing MGC026 in patients with advanced solid tumors
This study is testing a new treatment called MGC026 to see if it can help adults with advanced solid tumors that can't be removed or have spread to other parts of the body.
-
Testing MDX2001 for advanced solid tumors
This study is testing a new drug called MDX2001 to see if it can safely help people with advanced solid tumors like breast or colon cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.